{"id":"https://openalex.org/W7225625708","doi":"https://doi.org/10.3389/fmed.2026.2014176","title":"A case of severe recurrent VKH-like uveitis following BRAF/MEK inhibitor therapy: a case report and review of the literature","display_name":"A case of severe recurrent VKH-like uveitis following BRAF/MEK inhibitor therapy: a case report and review of the literature","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225625708","doi":"https://doi.org/10.3389/fmed.2026.2014176"},"language":"en","primary_location":{"id":"doi:10.3389/fmed.2026.2014176","doi":"https://doi.org/10.3389/fmed.2026.2014176","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.2014176","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.2014176/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.2014176/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029253729","display_name":"Lena Nour Juratli","orcid":"https://orcid.org/0000-0003-4118-091X","observed_orcids":["https://orcid.org/0000-0003-4118-091X"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lena Juratli","raw_affiliation_strings":["Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000375130","display_name":"Devayu A. Parikh","orcid":"https://orcid.org/0000-0003-4345-6262","observed_orcids":["https://orcid.org/0000-0003-4345-6262"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Devayu A. Parikh","raw_affiliation_strings":["Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010566352","display_name":"Christopher D. Conrady","orcid":"https://orcid.org/0000-0002-8531-0037","observed_orcids":["https://orcid.org/0000-0002-8531-0037"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christopher D. Conrady","raw_affiliation_strings":["Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah","Department of Pathology, University of Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah","institution_ids":["https://openalex.org/I223532165"]},{"raw_affiliation_string":"Department of Pathology, University of Utah","institution_ids":["https://openalex.org/I223532165"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5010566352"],"corresponding_institution_ids":["https://openalex.org/I223532165"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.27709999680519104,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.8009999990463257},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":1.0},{"id":"https://openalex.org/keywords/drug-induced-uveitis","display_name":"drug-induced uveitis","score":0.8679999709129333},{"id":"https://openalex.org/keywords/ocular-toxicity","display_name":"ocular toxicity","score":0.753000020980835},{"id":"https://openalex.org/keywords/recurrent-uveitis","display_name":"recurrent uveitis","score":0.8130000233650208},{"id":"https://openalex.org/keywords/panuveitis","display_name":"panuveitis","score":0.8669999837875366},{"id":"https://openalex.org/keywords/serous-retinal-detachment","display_name":"serous retinal detachment","score":0.9240000247955322},{"id":"https://openalex.org/keywords/choroidal-thickening","display_name":"choroidal thickening","score":0.8579999804496765},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.8220000267028809},{"id":"https://openalex.org/keywords/rechallenge","display_name":"drug rechallenge","score":0.8349999785423279},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.4909999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9351000189781189},{"id":"https://openalex.org/C2776194053","wikidata":"https://www.wikidata.org/wiki/Q280027","display_name":"Uveitis","level":2,"score":0.7034000158309937},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6072999835014343},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.5806999802589417},{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.5346999764442444},{"id":"https://openalex.org/C2776391266","wikidata":"https://www.wikidata.org/wiki/Q9612","display_name":"Fundus (uterus)","level":2,"score":0.44940000772476196},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.34389999508857727},{"id":"https://openalex.org/C2778024200","wikidata":"https://www.wikidata.org/wiki/Q2346242","display_name":"Retinal pigment epithelium","level":3,"score":0.3407000005245209},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.34040001034736633},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3375999927520752},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3163999915122986},{"id":"https://openalex.org/C2778313320","wikidata":"https://www.wikidata.org/wiki/Q550455","display_name":"Retinopathy","level":3,"score":0.3151000142097473},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.30480000376701355},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.29120001196861267},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2687999904155731},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.259799987077713}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fmed.2026.2014176","doi":"https://doi.org/10.3389/fmed.2026.2014176","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.2014176","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.2014176/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fmed.2026.2014176","doi":"https://doi.org/10.3389/fmed.2026.2014176","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.2014176","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.2014176/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306811","display_name":"Research to Prevent Blindness","ror":"https://ror.org/04drjs621"},{"id":"https://openalex.org/F4320337350","display_name":"National Eye Institute","ror":"https://ror.org/03wkg3b53"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225625708.pdf","grobid_xml":"https://content.openalex.org/works/W7225625708.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W1964537925","https://openalex.org/W1965370740","https://openalex.org/W2019441047","https://openalex.org/W2102342979","https://openalex.org/W2116376943","https://openalex.org/W2125544442","https://openalex.org/W2156078931","https://openalex.org/W2170661359","https://openalex.org/W2294989188","https://openalex.org/W2462147036","https://openalex.org/W2509999533","https://openalex.org/W2557663310","https://openalex.org/W2765292910","https://openalex.org/W2786816161","https://openalex.org/W2790436036","https://openalex.org/W2793817570","https://openalex.org/W2912028213","https://openalex.org/W3091549040","https://openalex.org/W3114998407","https://openalex.org/W3128925460","https://openalex.org/W3163521037","https://openalex.org/W4304175818","https://openalex.org/W4310497682","https://openalex.org/W4327733339","https://openalex.org/W4365141199","https://openalex.org/W4390206044","https://openalex.org/W4392542011","https://openalex.org/W4393163784","https://openalex.org/W4399594605","https://openalex.org/W4400379548","https://openalex.org/W4400534149","https://openalex.org/W4402349890","https://openalex.org/W4407876557","https://openalex.org/W4408409911","https://openalex.org/W4409009500","https://openalex.org/W4412656139","https://openalex.org/W4413971971"],"related_works":["https://openalex.org/W4392542011","https://openalex.org/W4407876557","https://openalex.org/W2557663310","https://openalex.org/W7165738719","https://openalex.org/W4402349890","https://openalex.org/W4385525457","https://openalex.org/W3091549040","https://openalex.org/W4405585578","https://openalex.org/W4283372803","https://openalex.org/W4389952163"],"abstract_inverted_index":{"BRAF":[0],"and":[1,38,67,74,88,99,114,117,128,132],"MEK":[2],"inhibitors":[3],"are":[4,13],"increasingly":[5],"used":[6],"as":[7],"targeted":[8],"anticancer":[9],"therapies.":[10],"However,":[11],"they":[12],"associated":[14],"with":[15,97],"vision-threatening":[16],"ocular":[17],"toxicities.":[18],"We":[19],"present":[20],"the":[21,80,122,129],"case":[22,103],"of":[23,45,82,125,140],"a":[24,39,64],"68-year-old":[25],"woman":[26],"who":[27],"developed":[28],"severe,":[29],"recurrent":[30,106],"VKH-like":[31,83,107],"uveitis":[32,84],"that":[33,105],"progressed":[34],"despite":[35,111],"corticosteroid":[36],"therapy":[37],"reduced-dose":[40],"drug":[41,72],"rechallenge.":[42],"The":[43],"constellation":[44],"findings,":[46],"including":[47],"bilateral":[48],"panuveitis,":[49],"exudative":[50],"retinal":[51,60],"detachments,":[52],"diffuse":[53],"choroidal":[54],"thickening,":[55],"subsequent":[56],"sunset-glow":[57],"fundus":[58],"changes,":[59],"pigment":[61],"epithelium":[62],"clumping,":[63],"negative":[65],"inflammatory":[66],"infectious":[68],"workup,":[69],"improvement":[70],"following":[71],"withdrawal,":[73],"recurrence":[75],"after":[76],"medication":[77],"rechallenge,":[78],"supported":[79],"diagnosis":[81],"secondary":[85],"to":[86],"dabrafenib":[87],"trametinib.":[89],"Although":[90],"some":[91],"patients":[92],"may":[93],"be":[94,145],"successfully":[95],"managed":[96],"corticosteroids":[98],"treatment":[100,119],"modification,":[101],"our":[102],"demonstrates":[104],"inflammation":[108],"can":[109],"progress":[110],"aggressive":[112],"local":[113],"systemic":[115],"immunosuppression":[116],"cancer":[118],"adjustments.":[120],"Given":[121],"increasing":[123],"number":[124],"reported":[126],"cases":[127],"high":[130],"incidence":[131],"hazard":[133],"ratios":[134],"observed":[135],"in":[136],"recent":[137],"studies,":[138],"development":[139],"formal":[141],"management":[142],"guidelines":[143],"should":[144],"considered.":[146]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}